ADVERTISEMENT

ASCO 2021 — OUTBACK study says additional chemo doesn’t improve survival in cervical cancer

Daniela Ovadia — Agenzia Zoe   |   Conference Report   |   14 June 2021
ADVERTISEMENT

Takeaway

  • Adjuvant chemotherapy (ACT) after standard cisplatin-based chemoradiation for women with locally advanced cervical cancer did not improve OS or PFS.

Why this matters

  • Carboplatin and paclitaxel are used as ACT for other cancers, so women with locally advanced cervical cancer were treated in the absence of evidence.
  • The results...

          

March Challenge

Ends in 11d 15h
left
right

Topic Challenges

left
right